NCT04541238 (ITRAF) is a clinical trial of MRI in Anal Fistula, sponsored by Treviso Regional Hospital.

Who is sponsoring NCT04541238?

NCT04541238 is sponsored by Treviso Regional Hospital.

What drugs are being tested in NCT04541238?

Interventions in NCT04541238: MRI.

What condition does NCT04541238 study?

NCT04541238 studies Anal Fistula.

Is NCT04541238 still recruiting?

NCT04541238 is currently status unknown. Last updated 9 September 2020.

Last reviewed 2020-09-09 · How we verify

NCT04541238: ITRAF

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Imaging Template for Reporting Anal Fistula

Status unknown Last updated 9 September 2020

What this trial tests

trial testing MRI in Anal Fistula in 100 participants. Status unknown.

Timeline

1 September 2020

Primary endpoint
31 December 2020

31 January 2021

Quick facts

Lead sponsor	Treviso Regional Hospital
Status	Status unknown
Study type	OBSERVATIONAL
Enrollment	100
Start date	1 September 2020
Primary completion	31 December 2020
Estimated completion	31 January 2021
Sites	1 location across Italy

Drugs / interventions tested

MRI — full drug profile →

Conditions studied

Anal Fistula — all drugs for Anal Fistula →

Sponsor

Treviso Regional Hospital

Who can join

18 and older, any sex, with Anal Fistula. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Magnetic resonance imaging (MRI) is the most used diagnostic tool for pre-operative assessment of anal fistula. However, there is lack of standardization in reporting this investigation. Moreover, reports may miss a number of key information for surgical planning. The aim of this study is to assess the effectiveness, reproducibility, and acceptability of a new template for reporting anal fistula, which may favor standardization in clinical practice and inform surgical decision making.

Publications & conference data

2 peer-reviewed publications reference this trial (live from Europe PMC):

Magnetic resonance imaging template to standardize reporting of anal fistulas.
Sudoł-Szopińska I, Santoro GA, Kołodziejczak M, Wiaczek A, et al · · 2021 · cited 12× · PMID 33400032 · DOI 10.1007/s10151-020-02384-6
Evaluation of Reporting Methods for Assessment and Surgical Planning of Perianal Fistulas.
Kharbech S, Mahmood NS, Qasem M, Abinahed J, et al · · 2026 · PMID 40360959 · DOI 10.1007/s10278-025-01524-4

Verify or expand the search:

Other trials of MRI

Trials testing the same drug.

NCT02831335 — Technical Development of Multi-Parametric Renocerebral MRI · recruiting
NCT07487870 — Radiographic Evaluation of Tumor Biology During Neoadjuvant Radiotherapy for Sarcoma · NA · not yet recruiting
NCT07567053 — Repetitive Transcranial Magnetic Stimulation on Motor Function and Meta-Plasticity in Cerebral Palsy: TMS-EEG Study · NA · not yet recruiting
NCT07537504 — Language Function Reorganization in Patients With Arteriovenous Malformations · not yet recruiting
NCT07217990 — Neoadjuvant Complete Response Customized Treatment Approach for Definitive Management of Breast Cancer · Phase 1, PHASE2 · not yet recruiting

Other recruiting trials for Anal Fistula

Currently open trials in the same condition.

NCT07477496 — Recurrence and Anal Fistula Patient Reported Outcomes Trial · recruiting
NCT07081373 — Study on Repeat Liposomal Bupivacaine for Post-Surgery Pain in Anal Fistula Patients. · NA · recruiting
NCT06803550 — Effect of Enhanced Recovery After Surgery for Benign Anorectal Conditions · NA · recruiting
NCT06303752 — Tissue Therapy of Transsphincteric Anal Fistula · Phase 1, PHASE2 · recruiting
NCT05641844 — A Double Blind, Randomized Controlled Study, Evaluating the Safety and Efficacy of RD2 Ver.02 For the Management of Anal · NA · recruiting

Other Treviso Regional Hospital trials

Trials by the same sponsor.

NCT07026513 — ORal Aminaphtone and Combined LidocainE · recruiting
NCT06638814 — HEmorrhoidAl Disease in Inflammatory Bowel Disease: a Multicenter Prospective Cohort Study · not yet recruiting
NCT05616455 — Efficacy and Safety of Propionibacterium Extract Gel Versus 0.4% Glyceryl Trinitrate Ointment in the Treatment of Chroni · Phase 4 · completed
NCT04488549 — Delayed Colorectal Cancer Care During Coronavirus Disease (COVID-19) Pandemic (DECOR-19) · completed

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT04541238 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Treviso Regional Hospital
Last refreshed: 9 September 2020

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT04541238.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing